Aigen Investment Management, LP Ani Pharmaceuticals Inc Transaction History

Aigen Investment Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$32.97 - $56.85 $206,590 - $356,222	-6,266 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$26.48 - $35.99 $12,472 - $16,951	-471 Reduced 6.99%	6,266 $206,000
Q2 2021 Aug 10, 2021	SELL	$31.86 - $38.6 $38,996 - $47,246	-1,224 Reduced 15.37%	6,737 $236,000
Q1 2021 May 11, 2021	SELL	$28.4 - $36.14 $28,513 - $36,284	-1,004 Reduced 11.2%	7,961 $288,000
Q4 2020 Feb 12, 2021	BUY	$23.69 - $31.47 $6,870 - $9,126	290 Added 3.34%	8,965 $260,000
Q3 2020 Nov 06, 2020	SELL	$26.38 - $33.1 $95,073 - $119,292	-3,604 Reduced 29.35%	8,675 $245,000
Q2 2020 Aug 10, 2020	BUY	$29.93 - $50.1 $367,510 - $615,177	12,279 New	12,279 $397,000

211

19.2M

3.4K

10.8K

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $950M
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.